BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $231,434 | +11.4% | 5,415 | +0.7% | 0.03% | +3.6% |
Q4 2023 | $207,789 | -6.6% | 5,375 | -8.8% | 0.03% | +7.7% |
Q3 2023 | $222,498 | -15.4% | 5,896 | +2.2% | 0.03% | -13.3% |
Q2 2023 | $262,878 | +13.1% | 5,770 | +0.7% | 0.03% | +3.4% |
Q1 2023 | $232,501 | -22.6% | 5,732 | -2.7% | 0.03% | -25.6% |
Q4 2022 | $300,397 | -4.9% | 5,894 | +0.4% | 0.04% | -13.3% |
Q3 2022 | $316,000 | -16.2% | 5,872 | -0.1% | 0.04% | -11.8% |
Q2 2022 | $377,000 | -16.8% | 5,876 | +0.7% | 0.05% | -15.0% |
Q1 2022 | $453,000 | -9.9% | 5,838 | -0.4% | 0.06% | -4.8% |
Q4 2021 | $503,000 | +7.9% | 5,859 | +1.1% | 0.06% | -3.1% |
Q3 2021 | $466,000 | -0.4% | 5,796 | -0.3% | 0.06% | -1.5% |
Q2 2021 | $468,000 | -4.3% | 5,814 | +0.3% | 0.07% | -13.2% |
Q1 2021 | $489,000 | +17.8% | 5,796 | +11.9% | 0.08% | -7.3% |
Q4 2020 | $415,000 | +1.5% | 5,178 | +1.9% | 0.08% | -11.8% |
Q3 2020 | $409,000 | -6.0% | 5,081 | +0.5% | 0.09% | -15.5% |
Q2 2020 | $435,000 | +5.1% | 5,055 | -0.8% | 0.11% | 0.0% |
Q1 2020 | $414,000 | -1.9% | 5,097 | +1.0% | 0.11% | +17.0% |
Q4 2019 | $422,000 | – | 5,049 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |